UPDATE 1-Glaxo cuts Cervarix price by 30 pct in Canada
October 25, 2010 at 06:34 AM EDT
LONDON, Oct 25 (Reuters) - GlaxoSmithKline has cut the price of its cervical cancer vaccine Cervarix by 30 percent in Canada in a bid to encourage greater uptake of the product.
